Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	74.38	61.35	61.33	52.39	45.19
Revenue Growth (YoY)	21.24%	0.03%	17.07%	15.95%	-
Cost of Revenue	-	44.95	44.03	36.42	32.23
Gross Profit	74.38	16.4	17.3	15.97	12.95
Selling, General & Admin	-	16.02	16	13.39	10.53
Other Operating Expenses	73.32	-0.66	-0.27	-	-
Operating Expenses	73.32	15.36	15.75	13.4	10.53
Operating Income	1.07	1.04	1.55	2.57	2.42
Interest Expense	-	-0.51	-0.48	-0.3	-0.37
Other Non Operating Income (Expenses)	-0	-	-	0.15	0.48
EBT Excluding Unusual Items	1.07	0.53	1.08	2.43	2.53
Gain (Loss) on Sale of Assets	-	-	0.01	-	-
Pretax Income	1.07	0.53	1.09	2.43	2.53
Income Tax Expense	0.25	0.35	0.4	0.41	0.37
Net Income	0.82	0.18	0.69	2.01	2.16
Net Income to Common	0.82	0.18	0.69	2.01	2.16
Net Income Growth	365.95%	-74.36%	-65.95%	-6.87%	-
Shares Outstanding (Basic)	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2
Shares Change (YoY)	-0.16%	-	-	-	-
EPS (Basic)	0.54	0.12	0.45	1.33	1.42
EPS (Diluted)	0.54	0.12	0.45	1.33	1.42
EPS Growth	366.72%	-74.36%	-65.95%	-6.87%	-
Free Cash Flow	5.82	1.1	1	-0.64	-2.82
Free Cash Flow Per Share	3.84	0.72	0.66	-0.42	-1.86
Dividend Per Share	-	-	1.587	-	-
Gross Margin	100.00%	26.73%	28.21%	30.49%	28.67%
Operating Margin	1.44%	1.70%	2.54%	4.91%	5.36%
Profit Margin	1.10%	0.29%	1.12%	3.84%	4.79%
Free Cash Flow Margin	7.83%	1.79%	1.63%	-1.22%	-6.25%
EBITDA	2.71	2.68	2.98	3.64	3.32
EBITDA Margin	3.64%	4.37%	4.86%	6.94%	7.34%
D&A For EBITDA	1.64	1.64	1.43	1.06	0.9
EBIT	1.07	1.04	1.55	2.57	2.42
EBIT Margin	1.44%	1.70%	2.54%	4.91%	5.36%
Effective Tax Rate	23.31%	66.80%	36.82%	16.94%	14.61%
Advertising Expenses	-	0.1	0.27	0.09	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.